#Largemolecule drugs, or #biologics, are transforming #healthcare, offering new possibilities for #rarecancers and #autoimmunedisorders—conditions once thought untreatable. But with innovation comes complexity. Developing and manufacturing these #largemoleculedrugs, especially at scale, presents challenges that #biotech companies must overcome. Our latest #blog, “Understanding large molecule drugs,” explores these challenges in detail and also highlights the opportunities #biologics bring to today’s #pharmaceutical landscape. Read it here: https://spr.ly/60420QFW0
Patheon
制药业
Waltham，Massachusetts 78,443 位关注者
An integrated CDMO partner for every step in your drug development journey
关于我们
Thermo Fisher Scientific provides industry-leading pharma services for drug development, clinical trial logistics, and commercial manufacturing through our Patheon? brand. We partner with customers in the pharmaceutical, biotech, and life sciences industries as their trusted CDMO to deliver medicine to patients faster. We believe that doing this successfully not only requires science, technology, and world-class expertise, but also requires a strategic partnership—bonded by key elements such as trust, communication, and collaboration. We embed these elements into every operation, interaction, and step in the drug development journey. With more than 60 locations around the world, we are committed to providing integrated, end-to-end solutions across all phases of development. Our pharma services include API, biologics, viral vectors, cGMP plasmids, formulation, clinical trials solutions, logistics services, commercial manufacturing, and packaging. We couple our scientific and technical excellence in these areas with a strategic partnership to provide customers of all sizes access to a global network of facilities and dedicated experts across the Americas, Europe, Asia, and Australia. At Thermo Fisher Scientific, we understand that developing novel therapies and moving them from discovery to patients is a complex, high-risk process. Every customer has different needs, and every newly discovered drug has a unique pathway to reach the market. As a global, full-service CDMO, we help our partners bring innovative molecules and life-changing therapies to market as efficiently and safely as possible.
- 网站
-
https://www.patheon.com/us/en/home.html
Patheon的外部链接
- 所属行业
- 制药业
- 规模
- 超过 10,001 人
- 总部
- Waltham，Massachusetts
- 类型
- 上市公司
- 领域
- Pharmaceutical Development Services、Biologics、Commercial Manufacturing、API Supply、Softgels、Early Development和Cell and Gene Therapy
地点
动态
-
Thermo Fisher Scientific is having a fantastic time at #DCATWeek2025! From our exclusive #GoldRoomReception to our bustling #HospitalitySuite, we’re connecting with more #biotech and #pharma partners than ever before. The future of #drugdevelopment is here, and the excitement is real. Have you explored our Accelerator? Drug Development, 360° #CDMO and #CRO solutions yet? Check them out here: https://spr.ly/60410qNb7 We can continue the conversation after #DCATWeek2025 ends. Do you have any follow-up questions about anything we've covered? Contact us here: https://spr.ly/60420qNbC
-
-
At DCAT’s Member Company Announcement Forum, Jennifer Cannon , president of commercial operations for pharma services, shared a roundup on how Thermo Fisher Scientific is strategically advancing capacity, speed and integration capabilities this year. The developments highlighted laid out a clear picture of our support for the evolving needs of our partners across biotech and biopharma, including: ?? Investing in Accelerator? Drug Development with cross-network digital enablement and a new CMC portfolio team. ?? Scaling drug substance capabilities, specifically for biologics and emerging modalities. ?? Driving key updates for high-demand drug products, across both sterile and oral solid dose formats. ?? Maintaining clinical supply and trial services network growth. ?? Expanding bioproduction services and supply chain solutions. Learn how Thermo Fisher Scientific compares to other CDMOs and CROs https://spr.ly/60450muad Stay tuned for more insights from #DCATWeek2025!
-
-
Thermo Fisher Scientific here, coming at you live from #DCATWeek2025 in #NewYorkCity. We’re excited to be in the #BigApple, surrounded by our colleagues and coworkers in the #biotech and #pharma #drugdevelopment industry. Thank you as well to Sheng Cui from NewAmsterdam Pharma Corporation and our very own Luke Wilson for presenting our case study, “Beyond supply: How a strategic partnership drove efficiency and innovation in global trials,” during this morning’s Partnering for Innovation in Manufacturing & Supply event. If you missed either of these talks, don’t worry—we can catch you up during a 1:1 meeting. In the meantime, check out the main reason why we’re here: https://spr.ly/60430ciIt
-
-
-
-
-
+2
-
-
Choosing the right #packaging and #labeling partner is critical for emerging #biotech companies conducting #clinicaltrials. Thermo Fisher Scientific’s latest #eBook, “Global reach, biotech speed,” highlights three non-negotiable qualities to look for: ?? Agility across all trial phases ?? A risk-mitigated supply chain ?? Expert regulatory guidance It also explores core capabilities—such as #smartpackaging solutions—that help ensure the success of scientific studies. Get the eBook here: https://spr.ly/604709siH
-
-
Otto Jurrius, general manager of Thermo Fisher Scientific’s biologics facility in #Groningen, understands what it takes to successfully advance #biologic therapies from #preclinical development to #clinicalmanufacturing. In our latest blog, Otto shares his insights on the key dos and don’ts of #biologics manufacturing—including why selecting the right #cellline is an all-important decision from the start. Take advantage of Otto’s insights here: https://spr.ly/60450d2DT
-
Thermo Fisher Scientific is honored to be named a winner of the 2025 #CDMOLeadershipAwards in the “#SmallMolecule Dosage Form” Global category. A huge thank you to Outsourced Pharma, Life Science Connect, and Orientation Marketing for this recognition, and to our incredible #biotech and #pharma partners who have trusted us and voted us into this prestigious program for 12 consecutive years. Our commitment to #innovation and #excellence in the #biopharmaceutical industry remains stronger than ever. Every day, we work to be the #CDMO partner you can trust to accelerate your #drugdevelopment journey and get treatments to #patients faster. Here's to many more years of collaboration! Learn more about our #oralsoliddose offerings here: https://spr.ly/60440nf8i
-
-
#DCATWeek2025 is days away—is your schedule set yet? Don’t forget to attend the #MemberCompanyAnnouncementForum on Monday, March 17, at 9:40 a.m. ET, where Jennifer Cannon, president of commercial at Thermo Fisher Scientific, will deliver updates and insights about our #drugdevelopment initiatives. Additionally, join us at the “Partnering for Innovation in Manufacturing and Supply” event to learn how we helped NewAmsterdam Pharma Corporation navigate the complexities of a cardiovascular #clinicaltrial spanning 835 sites and 12,000+ patients. Our #casestudy, “Beyond supply: How a strategic partnership drove efficiency and innovation in global trials,” will be featured there. ?? When: Tuesday, March 18, from 8–9:30 a.m. ET ?? Where: InterContinental Barclay, Grand Ballroom (2nd Floor) ?? Who: Walk-ins available on a first-come, first-served basis Want to chat about these talks? Schedule a meeting here: https://spr.ly/60480p9qo
-
-
#Artificialintelligence-powered #predictivemodeling is advancing #drugdevelopment in many ways. However, traditional #experimentalvalidation is still needed—especially when evaluating the solid-state properties of #activepharmaceuticalingredients (#APIs). Our upcoming #webinar will cover this topic, highlighting real-world case studies that illustrate how the integration of #AI and #experimental strategies can help: ?? Overcome challenges ?? Improve decision-making ?? Drive meaningful results At Thermo Fisher Scientific, we can’t wait to cover this conversation. Register here: https://spr.ly/60400Rxjp
-
-
Patheon转发了
Today’s #clinicaltrial landscape is constantly evolving. From enrolling the right participants to navigating complex regulations to managing unforeseen events. To navigate this uncertainty requires robust setup and planning processes to ensure the validity of the study outcomes. Our newly enhanced Trial Setup and Planning (TSP) system is designed to optimize your study while empowering you to achieve greater efficiency, accuracy, and success in your clinical trial planning and execution. Watch our overview to learn more: https://spr.ly/6046VpAz4